Schizophrenia risk to onset: Neurobiology and prevention

精神分裂症的发病风险：神经生物学和预防

• 批准号: 6875741
• 负责人: CHERYL MARY CORCORAN
• 金额: $ 17.68万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-04-01 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6875741
• 关键词: adolescence (12-20); behavior prediction; behavioral /social science research tag; clinical research; cognition; cortisol; disease /disorder model; disease /disorder onset; disease /disorder prevention /control; drug abuse; early diagnosis; human subject; hypothalamic pituitary adrenal axis; model design /development; neurobiology; patient oriented research; psychosis; schizophrenia; statistics /biometry; stress

DESCRIPTION (provided by applicant): This revised application for a Mentored Patient-Oriented Research Career Development Award (K23) presents a plan for Dr. Cheryl Corcoran to pursue training and research in the prospective assessment of the schizophrenia prodrome, specifically risk factors, intervening variables and markers associated with the onset of psychosis. The goals of the training and research plan are integrated around the hypothesis that the neural diathesis of schizophrenia liability involves a vulnerability to develop psychosis in the context of psychosocial stress. Dr. Corcoran currently has experience in studying 1) the schizophrenia prodrome and 2) stress exposure and its correlates in schizophrenia. Under the sponsorship of Dr. Malaspina, and drawing upon resources at both NYSPI/Columbia and Hillside Hospital, Dr. Corcoran's training plan combines formal coursework and direct supervision with clinical research experience and training. Dr. Corcoran has established a prodromal research clinic at NYSPI, entitled the "Center of Prevention and Evaluation" (COPE). The training plan involves 1) clinical methodologies in the assessment of stress and the HPA axis in schizophrenia (Malaspina); 2) increased expertise in prodromal research and neuropsychology (Cornblatt); 3) data analysis in longitudinal studies (Begg) and 4) adolescent cognitive and social development (Kestenbuam). The research plan is a prospective cohort study of prodromal patients that employs clinical methodologies that probe HPA axis function, prodromal symptoms, and psychosocial stress exposure. The hypotheses are that baseline stress-reactivity (stress reactive cortisol and impaired tolerance to normal stress) and intervening life events will increase risk for psychosis in prodromal patients. Important covariates are also evaluated, including cognition, early trauma, and medication and substance use. This study will provide the applicant with the knowledge and research experience necessary to apply for an R01 to further evaluate risk factors, mediators and markers of psychosis onset in prodromal patients.

描述（由申请人提供）：这份修订后的申请为指导的以患者为导向的研究职业发展奖（K23）提出了一项计划，供谢丽尔·科科伦博士在精神分裂症前驱症状的前瞻性评估中进行培训和研究，特别是风险因素，干预变量和与精神病发作相关的标志物。培训和研究计划的目标是围绕这样一个假设，即精神分裂症易感性的神经素质涉及在心理社会压力的背景下发展精神病的脆弱性。Corcoran博士目前在研究1）精神分裂症前驱症状和2）精神分裂症的应激暴露及其相关性方面有经验。在Malaspina博士的赞助下，并利用NYSPI/哥伦比亚和希尔赛德医院的资源，Corcoran博士的培训计划将正式课程和直接监督与临床研究经验和培训相结合。Corcoran博士在NYSPI建立了一个前驱研究诊所，名为“预防和评估中心”（科普）。培训计划包括：1）精神分裂症压力和HPA轴评估的临床方法（Malaspina）; 2）增加前驱研究和神经心理学方面的专业知识（Cornblatt）; 3）纵向研究中的数据分析（Begg）和4）青少年认知和社会发展（Kestenbuam）。该研究计划是一项前驱患者的前瞻性队列研究，采用临床方法，探测HPA轴功能，前驱症状和心理社会压力暴露。假设是，基线应激反应（应激反应性皮质醇和正常应激耐受性受损）和干预生活事件将增加前驱患者的精神病风险。重要的协变量也进行了评估，包括认知，早期创伤，药物和物质的使用。本研究将为申请人提供申请R 01所需的知识和研究经验，以进一步评估前驱患者精神病发作的风险因素、介质和标志物。